Catalyst Biosciences Inc (NASDAQ:CBIO)
| 4.30 Delayed Data As of 3:59pm ET |  -0.08 / -1.83%Today’s Change | 4.05 Today|||52-Week Range 8.22 | -31.85% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 1.8M | 399.0K | 1.0M | 6.0K | |
| Depreciation And Amortization | 470.0K | 389.0K | 173.0K | 149.0K | ||
| Operating Expenses | Gross Income | -- | -- | -- | -- | -- |
| General Expenses | 15.1M | 19.4M | 22.7M | 33.7M | ||
| Research And Development | 6.0M | 10.6M | 12.8M | 21.5M | ||
| Total Operating Expenses | 15.6M | 19.8M | 22.8M | 33.8M | ||
| Non-Operating Expenses | Operating Income | -13.8M | -19.4M | -21.8M | -33.8M | |
| Extraordinary Credit | 333.0K | 1.2M | 0.00 | 0.00 | ||
| Extraordinary Charge | 0.00 | -1.0M | 0.00 | 0.00 | ||
| Interest Expense On Debt | 1.5M | 0.00 | 0.00 | 0.00 | ||
| Other Expenses | 0.00 | 2.3M | 261.0K | 3.8M | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -14.8M | -16.9M | -21.6M | -30.1M | |
| Preferred Dividend | 0.00 | 0.00 | -4.0M | 0.00 | ||
| Net Income | -14.8M | -16.9M | -21.6M | -30.1M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 295.3K | 779.2K | 3.4M | 11.2M | |
| Shares To Calculate EPS Diluted | 295.3K | 779.2K | 3.4M | 11.2M | ||
| Earnings Per Share | EPS | -$49.95 | -$326.25 | -$7.45 | -$2.68 | |
| EPS Diluted | -$49.99 | -$21.75 | -$7.45 | -$2.68 | ||
